Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Cash from Investing Activities: 2010-2024

Historic Cash from Investing Activities for EyePoint Pharmaceuticals (EYPT) over the last 15 years, with Dec 2024 value amounting to -$219.4 million.

  • EyePoint Pharmaceuticals' Cash from Investing Activities fell 99.40% to $101,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $16.6 million, marking a year-over-year increase of 209.25%. This contributed to the annual value of -$219.4 million for FY2024, which is 6517.04% down from last year.
  • Latest data reveals that EyePoint Pharmaceuticals reported Cash from Investing Activities of -$219.4 million as of FY2024, which was down 6,517.04% from -$3.3 million recorded in FY2023.
  • In the past 5 years, EyePoint Pharmaceuticals' Cash from Investing Activities ranged from a high of -$362,000 in FY2020 and a low of -$219.4 million during FY2024.
  • Over the past 3 years, EyePoint Pharmaceuticals' median Cash from Investing Activities value was -$17.3 million (recorded in 2022), while the average stood at -$80.0 million.
  • As far as peak fluctuations go, EyePoint Pharmaceuticals' Cash from Investing Activities tumbled by 9,049.45% in 2021, and later skyrocketed by 80.80% in 2023.
  • Over the past 5 years, EyePoint Pharmaceuticals' Cash from Investing Activities (Yearly) stood at -$362,000 in 2020, then tumbled by 9,049.45% to -$33.1 million in 2021, then soared by 47.87% to -$17.3 million in 2022, then spiked by 80.80% to -$3.3 million in 2023, then slumped by 6,517.04% to -$219.4 million in 2024.